These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10377468)
1. New photosensitizers for photodynamic therapy in gastroenterology. Bown SG; Rogowska AZ Can J Gastroenterol; 1999 Jun; 13(5):389-92. PubMed ID: 10377468 [TBL] [Abstract][Full Text] [Related]
2. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. Gossner L; May A; Sroka R; Ell C Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus. Dunn J; Lovat L Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960 [TBL] [Abstract][Full Text] [Related]
4. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia. Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171 [TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. Barr H Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):421-37. PubMed ID: 10899256 [TBL] [Abstract][Full Text] [Related]
6. The biology of photodynamic therapy in the gastrointestinal tract. Bown SG; Lovat LB Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):533-50. PubMed ID: 10899262 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy. Davila ML Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498 [TBL] [Abstract][Full Text] [Related]
8. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Panjehpour M; Overholt BF Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927 [TBL] [Abstract][Full Text] [Related]
9. Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy. Shinohara Y; Endo Y; Abe C; Shiba I; Ishizuka M; Tanaka T; Yonemura Y; Ogura SI; Tominaga M; Yamada H; Uto Y Photodiagnosis Photodyn Ther; 2017 Dec; 20():182-188. PubMed ID: 29056554 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study. Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528 [TBL] [Abstract][Full Text] [Related]
11. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus. Mackenzie GD; Jamieson NF; Novelli MR; Mosse CA; Clark BR; Thorpe SM; Bown SG; Lovat LB Lasers Med Sci; 2008 Apr; 23(2):203-10. PubMed ID: 17610005 [TBL] [Abstract][Full Text] [Related]
12. Safe ablation of the anal mucosa and perianal skin in rats using Photodynamic Therapy--a promising approach for treating Anal Intraepithelial Neoplasia. Abbasakoor F; Woodhams J; Farooqui N; Novelli M; Bown S; MacRobert A; Boulos P Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):566-74. PubMed ID: 24284113 [TBL] [Abstract][Full Text] [Related]
13. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study. Ackroyd R; Brown N; Vernon D; Roberts D; Stephenson T; Marcus S; Stoddard C; Reed M Photochem Photobiol; 1999 Oct; 70(4):656-62. PubMed ID: 10546561 [TBL] [Abstract][Full Text] [Related]
14. [Photodynamic therapy in gastroenterology]. Shim CS Korean J Gastroenterol; 2005 Mar; 45(3):153-61. PubMed ID: 15778541 [TBL] [Abstract][Full Text] [Related]
15. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Panjehpour M; Overholt BF; Haydek JM; Lee SG Am J Gastroenterol; 2000 Sep; 95(9):2177-84. PubMed ID: 11007214 [TBL] [Abstract][Full Text] [Related]
16. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. Kelty CJ; Ackroyd R; Brown NJ; Brown SB; Reed MW Surg Endosc; 2004 Mar; 18(3):452-8. PubMed ID: 14752635 [TBL] [Abstract][Full Text] [Related]
17. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080 [TBL] [Abstract][Full Text] [Related]
18. Light dose fractionation to enhance photodynamic therapy using 5-aminolevulinic acid in the normal rat colon. Curnow A; McIlroy BW; Postle-Hacon MJ; MacRobert AJ; Bown SG Photochem Photobiol; 1999 Jan; 69(1):71-6. PubMed ID: 10063802 [TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Foroulis CN; Thorpe JA Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389 [TBL] [Abstract][Full Text] [Related]
20. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus. Gray J; Fullarton GM Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]